Apposite Capital Overview

Apposite Capital is a London-based investment firm focused on healthcare services and life sciences companies. They work closely with management teams, offering commercial and strategic support through a network of senior advisors. Their mission is to deliver high-quality, efficient, and cost-effective care solutions, aiming to create a positive impact across the healthcare sector.

Is Apposite Capital the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Apposite Capital, along with a list of other relevant VCs, is available on Hopohopo.io.

Apposite Capital

VC Fund

Investment focus

Invest in

  • Baltics
  • Nordics
  • Western Europe
  • Southern Europe
  • Central Eastern Europe

Product type

  • Software
  • Hardware
  • Software-enabled hardware
  • Services
  • Drugs / Pharma

Industries / verticals

  • BioTech & Life Sciences
  • Digital & Consumer health
  • Health Data, Healthcare Systems & Infrastructure
  • MedTech & Devices
  • PharmaTech

Stages

Series A, Series B or later

First ticket size

£1,000,000 - £10,000,000

How to approach funds like Apposite Capital

When approaching Apposite Capital, founders should highlight a clear path to scalable impact within healthcare, demonstrating how their solution addresses pressing sector inefficiencies or unmet needs. Emphasize strong management capabilities and a readiness to collaborate closely, as Apposite values hands-on partnerships and leverages its advisory network. Articulate how your business model aligns with value-based care and can deliver measurable improvements in patient outcomes or system efficiency.

Find the best-fitting investors for your startup

Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.

Find your investor matches
Investor funnel board

Check the next investor profile